More on DNLI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Denali Therapeutics (NQ:DNLI)
Delayed: 23.31 -0.18 (0.77%)
Prev. Close $23.49  
Open$24.17 
52 Wk High$ 
52 Wk Low$ 
Day High$24.65 
Day Low$23.21 
P/E N/A  
EPS$ 
Volume2,518,393 

Friends, Peers and Foes (?): RPRX, ABBV, ARVN, ASND, ATYR (more...)

Jun 18, 2026 08:02 AM Form 8-K Denali Therapeutics Inc. For: Jun 12
Jun 18, 2026 08:00 AM Denali Therapeutics to sell priority review voucher for $195M
Jun 18, 2026 08:00 AM Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
Jun 16, 2026 09:27 AM UBS Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
Jun 5, 2026 04:46 PM Form 4 Denali Therapeutics Inc. For: Jun 03 Filed by: FLATLEY JAY T
Jun 5, 2026 04:46 PM Form 4 Denali Therapeutics Inc. For: Jun 03 Filed by: Klein Peter S
Jun 5, 2026 04:46 PM Form 4 Denali Therapeutics Inc. For: Jun 03 Filed by: Krognes Steve E.
Jun 5, 2026 04:45 PM Form 4 Denali Therapeutics Inc. For: Jun 03 Filed by: Schenkein David P
Jun 5, 2026 04:45 PM Form 4 Denali Therapeutics Inc. For: Jun 03 Filed by: Thornberry Nancy
Jun 5, 2026 04:45 PM Form 4 Denali Therapeutics Inc. For: Jun 03 Filed by: Van Hauwermeiren Timothy
View All Articles

Entities mentioned with DNLI

View All Entities